Oxidative stress in cardio renal anemia syndrome: Correlations and therapeutic possibilities

Clinical Nephrology

Volumn 60, Issue SUPPL.1, 2003, Pages

  Siems, Werner ^a   Quast, S ^a   Carluccio, F ^b   Wiswedel, I ^c   Hirsch, D ^c   Augustin, W ^c   Kraemer, K ^d   Hampl, H ^e   Sommerburg, O ^f  

^a Herzog Julius Klinik GmbH & Co KG   (Germany)

^b I Veris delli Ponti Hosp Scorrano   (Italy)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

^d BASF SE   (Germany)

^e HUMBOLDT UNIVERSITY   (Germany)

^f UNIVERSITY OF ULM   (Germany)

Author keywords

Cardio renal anemia syndrome; Chronic renal failure; Heart; Homocysteine; Isoprostanes; Kidney; Lipid oxidation; Oxidative stress; Oxysterols; Renal anemia

Indexed keywords

4 HYDROXYNONENAL; ALDEHYDE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CATALASE; CHOLESTEROL; ERYTHROPOIETIN; GLUTATHIONE PEROXIDASE; HEMOGLOBIN; HOMOCYSTEINE; ISOPROSTANE DERIVATIVE; LIPID; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA;

ANEMIA; ANTIOXIDANT ACTIVITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CORRELATION FUNCTION; DISEASE SEVERITY; HEART INDEX; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HUMAN; INFLAMMATION; LINEAR SYSTEM; LIPID OXIDATION; LIPID PEROXIDATION; LIPOPHILICITY; MALNUTRITION; MEDICAL DOCUMENTATION; METABOLIC PARAMETERS; MORTALITY; OXIDATIVE STRESS; QUALITY OF LIFE; REVIEW; RISK FACTOR;

ANEMIA; CARDIOVASCULAR DISEASES; HUMANS; KIDNEY FAILURE, CHRONIC; OXIDATIVE STRESS; SYNDROME;

EID: 0038044813     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Alfrey AC 1994 Role of iron and oxygen radicals in the progression of chronic renal failure. Am J Kidney Dis 23: 183-187
2. Baliga R, Ueda N, Walker PD, Shah SV 1997 Oxidant mechanisms in toxic renal failure. Am J Kidney Dis 29: 465-477
3. Berweck S, Hennig L, Sternberg C, Dingerkus H, Ludat K, Hampl H 2000 Cardiac mortality prevention in uremic patients. Therapeutic strategies with particular attention to complete correction of renal anemia. Clin Nephrol 53 (Suppl 1-2000): S80-S85
4. Bhakdi S 1998a Complement and atherosclerosis: the unknown connection. Ann Med 30: 503-507
5. Bhakdi S 1998b Pathogenesis of atherosclerosis: the alternative hypothesis. J Interven Cardiol 11: 529-534
6. Bhakdi S 2002 Immunpathogenese der Atherosklerose - Die Mainzer Hypothese. Dtsch Med Wochenschr 127: 390-394
7. Carluccio F, Siems W, Stefanelli G, Sommerburg O, Grune T, Riedel E, Hampl H 2002 Homocysteine in chronic renal failure in relation to renal anemia and to oxidative stress parameters 4-hydroxynonenal and malondialdehyde. Clin Nephrol 58 (Suppl 1-2002): S26-S30
8. Collaborative Group of the Primary Prevention Project (PPP) 2001 Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Lancet 357: 89-95
9. DeKeulenaer GW, Ushio-Fukai M, Yin QQ, Chung AB, Lyons PR, Ishizaka N, Rengarajan K, Taylor WR, Alexander RW, Griendling KK 2000 Convergence of redox-sensitive and mitogen-activated protein kinase signalling pathways in tumor necrosis factor-alpha-mediated monocyte chemoattractant protein-1 induction in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 20: D385-391
10. Eaton P, Li JM, Hearse DJ, Shattock MJ 1999 Formation of 4-hydroxy-2-nonenal-modified proteins in ischemic rat heart. Am J Physiol 276: H935-H943
11. Gale CR, Martyn C, Winter PD, Cooper C 1995 Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people. Br Med J 310: 1563-1566
12. GISSI-Prevenzione Investigators 1999 Dietry supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354: 447-455
13. Grune T, Sommerburg O, Siems WG 2000 Oxidative stress in anemia. Clin Nephrol 53 (Suppl 1-2000): S18-S22
14. 2 cholesterol. Am J Clin Nutr 60: 100-105
15. Hampl H 2000 Epilogue (what speaks in favor of a complete correction of renal anemia?). Why correct renal anemia completely. Clin Nephrol 53 (Suppl 1-2000): S87-S89
16. Hampl H, Sternberg C, Berweck S, Lange D, Lorenz F, Pohle C, Riedel E, Gogoll L, Hennig L 2002 Regression of left ventricular hypertrophy in hemodialysis patients is possible. Clin Nephrol 58 (Suppl 1-2002): S73-S96
17. Handelman GJ, Walter MF, Adhikarla R, Gross J, Dallal GE, Levin NW, Blumberg JB 2001 Elevated plasma F2-isoprostanes in patients on long-term hemodialysis. Kidney Int 59: 1960-1966
18. Harris A, Devaraj S, Jialal I 2002 Oxidative stress, alpha-tocopherol therapy, and atherosclerosis. Curr Atheroscler Rep 4: 373-380
19. Hattori R, Hernandez TE, Zhu L, Maulik N, Otani H, Kaneda Y, Das DK 2001 An essential role of the antioxidant gene Bcl-2 in myocardial adaptation to ischemia: an insight with antisense Bcl-2 therapy. Antioxid Redox Signal 3: 403-413
20. Hingtgen SD, Davisson RL 2001 Gene therapeutic approaches to oxidative stress-induced cardiac disease: principles, progress, and prospects. Antioxid Redox Signal 3: 433-449
21. Ide T, Tsutsui H, Hayashidani S, Kang D, Suematsu N, Nakamura K, Utsumi H, Hamasaki N, Takeshita A 2001 Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ Res 88: 529-535
22. Jacques PF, Sulsky SI, Perrone GA, Schaefer EJ 1994 Ascorbic acid and plasma lipids. Epidemiology 5: 19-26
23. Jialal I, Devaraj S 2002 Prospective vitamin E clinical trials. In: Packer L, Traber MG, Kraemer K, Frei B (eds): The antioxidant vitamins C and E. AOCS Press, Champaign, Illinois, pp 243-254
24. Jialal I, Devaraj S 2003 Antioxidants and atherosclerosis - don't throw out the baby with the bath water. Circulation 107: 926-928
25. Kijima Y, Hashimura K, Matsuura Y, Kato Y, Yasuda T, Ueda T, Orita Y, Fukunaga M 2001 Transcardiac 8-iso-prostaglandin F(2 alpha)generation from acute myocardial infarction heart: insight into abrupt reperfusion and oxidant stress. Prostaglandins Leukot Essent Fatty Acids 64: 161-166
26. Knekt P, Reunanen A, Jarvinen R, Seppanen R, Heliovaara M, Aromaa A 1994 Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol 139: 1180-1189
27. Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y, Bostick RM 1996 Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 334: 1156-1162
28. Lehr H-A, Sagban TA, Ihling C, Haehringer U, Hungerer K-D, Blumrich M, Reifenberg K, Bhakdi S 2001 Immunopathogenesis of atherosclerosis. Endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet. Circulation 104: 914-920
29. Leichtweis S, Ji LL 2001 Glutathione deficiency intensifies ischaemia-reperfusion induced cardiac dysfunction and oxidative stress. Acta Physiol Scand 172: 1-10
30. Loria CM 2002 Vitamin C status and cardiovascular disease: a review of prospective studies. In: Packer L, Traber MG, Kraemer K, Frei B (eds): The antioxidant vitamins C and E. AOCS Press, Champaign, Illinois, pp 105-115
31. Mezzetti A, Zuliani G, Romano F, Costantini F, Pierdomenico SD, Cuccurullo F, Fellin R 2001 Vitamin E and lipid peroxide plasma levels predict the risk of cardiovascular events in a group of healthy very old people. J Am Geriatr Soc 49: 533-537
32. Mitchinson MJ, Stephens NG, Parsons A, Bligh E, Schofield PM, Brown MJ 1999 Mortality in the CHAOS Trial. Lancet 353: 381-382
33. Miyata T, Kurokawa K, van Ypersele de Strihou C 2000 Relevance of oxidative and carbonyl stress to long-term uremic complications. Kidney Int 58 (Suppl 76): S120-S125
34. Nishida M, Maruyama Y, Tanaka R, Komani K, Nagao T, Kurose H 2000 G alpha(i) and G alpha(o) are target proteins of reactive oxygen species. Nature 408: 492-495
35. Pandey DK, Shekelle R, Selwyn BJ, Tangney C, Stamler J 1995 Dietary vitamin C and beta-carotene and risk of death in middle-aged men. The Western Electric Study. Am J Epidemiol 142: 1269-1278
36. Pryor W 2000 Vitamin E and heart disease: basic science to clinical intervention trials. Free Radic Biol Med 28: 141-164
37. Rajagopalan S, Kurz S, Muenzel T, Tarpey M, Freeman BA, Griendling KK, Arrison DG 1996 Angiotensin-II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97: 1916-1923
38. Ramires PR, Ji LL 2001 Glutathione supplementation and training increases myocardial resistance to ischemia-reperfusion in vivo. Am J Physiol 281: H679-H688
39. Rapola JM, Virtamo J, Ripatt S, Huttunen JK, Albanes D, Taylor PR, Heinonen OP 1997 Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of majorcoronary events in men with previous myocardial infarction. Lancet 349: 1715-1720
40. Sahyoun NR, Jacques PF, Russell RM 1996 Carotenoids, vitamins C and E and mortality in an elderly population. Am J Epidemiol 144: 501-511
41. Salonen JT 2002 Clinical trials testing cardiovascular benefits of antioxidant supplementation. Free Radical Res 36: 1299-1306
42. Salonen RM, Nyyssönen K, Kaikkonen J, Porkkala-Sarataho E, Voutilainen S, Rissanen TH, Tuomainen T-P, Valkonen V-P, Ristonmaa U, Lakka H-M, Vanharanta M, Salonen JT, Poulsen HE 2003 Sex-year effect of combined vitamin C and E supplementation on atherosclerotic progression - the antioxidant supplementation in atherosclerosis prevention (ASAP) study. Circulation 107: 947-953
43. Siems WG, Sommerburg O, Grune T 2000 Erythrocyte free radical and energy metabolism. Clin Nephrol 53 (Suppl 1-2000): S9-S17
44. Siems W, Quast S, Carluccio F, Wiswedel I, Hirsch D, Autustin W, Hampl H, Riehle M, Sommerburg O 2002a Oxidative stress in chronic renal failure as a cardiovascular risk factor. Clin Nephrol 58 (Suppl 1-2002): S12-S19
45. Siems W, Carluccio F, Grune T, Jakstadt M, Quast S, Hampl H, Sommerburg O 2002b Elevated serum concentration of cardiotoxic lipid peroxidation products in chronic renal failure in relation to severity of renal anemia. Clin Nephrol 58 (Suppl 1-2002): S20-S25
46. Silverberg DS, Wexler D, Blum M, Sheps D, Schwartz D, Yachnin T, Baruch R 2001 Aggressive therapy of congestive heart failure and associated chronic renal failure with medications, and correction of anemia stops the progression of both diseases. Periton Dial Int 21 (Suppl 3): S236-S240
47. Silverberg DS, Wexler D, Blum M, Tchebiner J, Sheps D, Keren G, Schwartz D, Baruch R, Yachnin T, Shaked M, Zubkov A, Steinbruch S, Iaina A 2002 The correction of anemia in severe resistant heart failure with erythropoietin and intravenous iron prevents the progression of both the heart and the renal failure and markedly reduces hospitalization. Clin Nephrol 58 (Suppl 1-2002): S37-S45
48. Simon JA 1992 Vitamin C and cardiovascular disease: A review. J Am Coll Nutr 11: 107-125
49. Simon JA, Schreiber GB, Crawford PB, Frederick MM, Sabry ZI 1993 Dietary vitamin C and serum lipids in black and white girls. Epidemiology 4: 537-542
50. Sommerburg O, Grune T, Hampl H, Riedel E, van Kuijk FJGM, Ehrich JHH, Siems WG 1997 Does long-term treatment of renal anaemia with recombinant erythropoietin influence oxidative stress in hemodialysed patients? Nephrol Dial Transplant 13: 2583-1587
51. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ, Brown MJ 1996 Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge heart antioxidant study (CHAOS). Lancet 347: 781-786
52. Trachtman H, Wilson D, Rao PS 1992 The role of oxygen-free radicals in the development of chronic renal failure. Life Sciences 50: 1877-1883
53. Walter MF, Blumberg JB, Dolnikowski GG, Handelman GJ 2000 Streamlined F2-isoprostane analysis in plasma and urine with high-performance liquid chromatography and gas chromatography/mass spectroscopy. Anal Biochem 280: 73-79
54. Wiswedel I, Hirsch D, Carluccio F, Hampl H, Augustin W, Siems W 2003 8-Epi-PGF2α and 9α, 11α-PGF2α serum concentrations in patients with chronic renal failure in relation to inflammation and renal anemia (Manuscript in preparation)
55. Wratten ML, Tetta C, Ursini F, Sevanian A 2000 Oxidant stress in hemodialysis: prevention and treatment strategies. Kidney Int 58 (Suppl 76): S126-S132